Advertisement
Singapore markets close in 1 hour 55 minutes
  • Straits Times Index

    3,280.91
    -12.22 (-0.37%)
     
  • Nikkei

    37,628.48
    -831.60 (-2.16%)
     
  • Hang Seng

    17,269.09
    +67.82 (+0.39%)
     
  • FTSE 100

    8,040.38
    0.00 (0.00%)
     
  • Bitcoin USD

    64,306.30
    -2,479.66 (-3.71%)
     
  • CMC Crypto 200

    1,389.82
    +7.25 (+0.52%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • Dow

    38,460.92
    -42.77 (-0.11%)
     
  • Nasdaq

    15,712.75
    +16.11 (+0.10%)
     
  • Gold

    2,333.80
    -4.60 (-0.20%)
     
  • Crude Oil

    82.99
    +0.18 (+0.22%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • FTSE Bursa Malaysia

    1,570.79
    -0.69 (-0.04%)
     
  • Jakarta Composite Index

    7,151.69
    -22.84 (-0.32%)
     
  • PSE Index

    6,574.88
    +2.13 (+0.03%)
     

Will Moderna’s Tenure on the S&P 500 Index Be Short-Lived?

Moderna (NASDAQ: MRNA) is now officially a member of the S&P 500. In this Motley Fool Live video recorded on July 21, 2021, healthcare and cannabis bureau editor-analyst Olivia Zitkus and Motley Fool contributor Keith Speights discuss whether or not Moderna's tenure on the S&P 500 index will be short-lived. Let's go over to Moderna, which is now officially, I think today, a member of the S&P 500 Index.